Elizabeth Day: Sorry seems to be the cheapest word

Selpercatinib is the first drug from Loxo’s pipeline that Lilly has brought to market.Prior to the acquisition, Loxo won approval of Vitrakvi, which targets a different genetic mutation and is sold by Bayer AG.The MD is manufactured by B-ON, and the company...